Global Cephalosporin Market Research Report 2023(Status and Outlook)
Report Overview
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
Cephalosporin originally derived from the fungus Acremonium, which was previously known as ""Cephalosporium"".
Market competition is intense. Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals and Hospira are the top 5 of Cephalosporin, with about 30% market shares.
China is the largest supplier of Cephalosporin, with a production market share nearly 43%. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 22%.
Europe is the largest consumption place, with a consumption market share nearly 30%. Following Europe, North America is the second largest consumption place with the consumption market share of 25%.
The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation is about 37%.
Cephalosporin is widely used in d Oral drugs and Injection drugs. The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 55%.
The Global Cephalosporin Market Size was estimated at USD 3914.30 million in 2022 and is projected to reach USD 4465.53 million by 2029, exhibiting a CAGR of 1.90% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Cephalosporin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cephalosporin Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cephalosporin market in any manner.
Global Cephalosporin Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm
Market Segmentation (by Type)
First Generation Cephalosporin
Second Generation Cephalosporin
Third Generation Cephalosporin
Fourth Generation Cephalosporin
Market Segmentation (by Application)
Raspberry
Blueberry
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cephalosporin Market
Overview of the regional outlook of the Cephalosporin Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Cephalosporin
- 1.2 Key Market Segments
- 1.2.1 Cephalosporin Segment by Type
- 1.2.2 Cephalosporin Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Cephalosporin Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Cephalosporin Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Cephalosporin Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Cephalosporin Market Competitive Landscape
- 3.1 Global Cephalosporin Sales by Manufacturers (2018-2023)
- 3.2 Global Cephalosporin Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Cephalosporin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Cephalosporin Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Cephalosporin Sales Sites, Area Served, Product Type
- 3.6 Cephalosporin Market Competitive Situation and Trends
- 3.6.1 Cephalosporin Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Cephalosporin Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Cephalosporin Industry Chain Analysis
- 4.1 Cephalosporin Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Cephalosporin Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Cephalosporin Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Cephalosporin Sales Market Share by Type (2018-2023)
- 6.3 Global Cephalosporin Market Size Market Share by Type (2018-2023)
- 6.4 Global Cephalosporin Price by Type (2018-2023)
- 7 Cephalosporin Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Cephalosporin Market Sales by Application (2018-2023)
- 7.3 Global Cephalosporin Market Size (M USD) by Application (2018-2023)
- 7.4 Global Cephalosporin Sales Growth Rate by Application (2018-2023)
- 8 Cephalosporin Market Segmentation by Region
- 8.1 Global Cephalosporin Sales by Region
- 8.1.1 Global Cephalosporin Sales by Region
- 8.1.2 Global Cephalosporin Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Cephalosporin Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Cephalosporin Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Cephalosporin Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Cephalosporin Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Cephalosporin Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Union Chempharma
- 9.1.1 Union Chempharma Cephalosporin Basic Information
- 9.1.2 Union Chempharma Cephalosporin Product Overview
- 9.1.3 Union Chempharma Cephalosporin Product Market Performance
- 9.1.4 Union Chempharma Business Overview
- 9.1.5 Union Chempharma Cephalosporin SWOT Analysis
- 9.1.6 Union Chempharma Recent Developments
- 9.2 NCPC
- 9.2.1 NCPC Cephalosporin Basic Information
- 9.2.2 NCPC Cephalosporin Product Overview
- 9.2.3 NCPC Cephalosporin Product Market Performance
- 9.2.4 NCPC Business Overview
- 9.2.5 NCPC Cephalosporin SWOT Analysis
- 9.2.6 NCPC Recent Developments
- 9.3 Qilu Antibiotics
- 9.3.1 Qilu Antibiotics Cephalosporin Basic Information
- 9.3.2 Qilu Antibiotics Cephalosporin Product Overview
- 9.3.3 Qilu Antibiotics Cephalosporin Product Market Performance
- 9.3.4 Qilu Antibiotics Business Overview
- 9.3.5 Qilu Antibiotics Cephalosporin SWOT Analysis
- 9.3.6 Qilu Antibiotics Recent Developments
- 9.4 Lupin Pharmaceuticals
- 9.4.1 Lupin Pharmaceuticals Cephalosporin Basic Information
- 9.4.2 Lupin Pharmaceuticals Cephalosporin Product Overview
- 9.4.3 Lupin Pharmaceuticals Cephalosporin Product Market Performance
- 9.4.4 Lupin Pharmaceuticals Business Overview
- 9.4.5 Lupin Pharmaceuticals Cephalosporin SWOT Analysis
- 9.4.6 Lupin Pharmaceuticals Recent Developments
- 9.5 Hospira
- 9.5.1 Hospira Cephalosporin Basic Information
- 9.5.2 Hospira Cephalosporin Product Overview
- 9.5.3 Hospira Cephalosporin Product Market Performance
- 9.5.4 Hospira Business Overview
- 9.5.5 Hospira Cephalosporin SWOT Analysis
- 9.5.6 Hospira Recent Developments
- 9.6 Dhanuka Laboratories
- 9.6.1 Dhanuka Laboratories Cephalosporin Basic Information
- 9.6.2 Dhanuka Laboratories Cephalosporin Product Overview
- 9.6.3 Dhanuka Laboratories Cephalosporin Product Market Performance
- 9.6.4 Dhanuka Laboratories Business Overview
- 9.6.5 Dhanuka Laboratories Recent Developments
- 9.7 Fukang
- 9.7.1 Fukang Cephalosporin Basic Information
- 9.7.2 Fukang Cephalosporin Product Overview
- 9.7.3 Fukang Cephalosporin Product Market Performance
- 9.7.4 Fukang Business Overview
- 9.7.5 Fukang Recent Developments
- 9.8 Dongying Pharmaceutical
- 9.8.1 Dongying Pharmaceutical Cephalosporin Basic Information
- 9.8.2 Dongying Pharmaceutical Cephalosporin Product Overview
- 9.8.3 Dongying Pharmaceutical Cephalosporin Product Market Performance
- 9.8.4 Dongying Pharmaceutical Business Overview
- 9.8.5 Dongying Pharmaceutical Recent Developments
- 9.9 Alkem
- 9.9.1 Alkem Cephalosporin Basic Information
- 9.9.2 Alkem Cephalosporin Product Overview
- 9.9.3 Alkem Cephalosporin Product Market Performance
- 9.9.4 Alkem Business Overview
- 9.9.5 Alkem Recent Developments
- 9.10 SALUBRIS
- 9.10.1 SALUBRIS Cephalosporin Basic Information
- 9.10.2 SALUBRIS Cephalosporin Product Overview
- 9.10.3 SALUBRIS Cephalosporin Product Market Performance
- 9.10.4 SALUBRIS Business Overview
- 9.10.5 SALUBRIS Recent Developments
- 9.11 LIVZON
- 9.11.1 LIVZON Cephalosporin Basic Information
- 9.11.2 LIVZON Cephalosporin Product Overview
- 9.11.3 LIVZON Cephalosporin Product Market Performance
- 9.11.4 LIVZON Business Overview
- 9.11.5 LIVZON Recent Developments
- 9.12 Hetero Drugs
- 9.12.1 Hetero Drugs Cephalosporin Basic Information
- 9.12.2 Hetero Drugs Cephalosporin Product Overview
- 9.12.3 Hetero Drugs Cephalosporin Product Market Performance
- 9.12.4 Hetero Drugs Business Overview
- 9.12.5 Hetero Drugs Recent Developments
- 9.13 CSPC
- 9.13.1 CSPC Cephalosporin Basic Information
- 9.13.2 CSPC Cephalosporin Product Overview
- 9.13.3 CSPC Cephalosporin Product Market Performance
- 9.13.4 CSPC Business Overview
- 9.13.5 CSPC Recent Developments
- 9.14 TEVA
- 9.14.1 TEVA Cephalosporin Basic Information
- 9.14.2 TEVA Cephalosporin Product Overview
- 9.14.3 TEVA Cephalosporin Product Market Performance
- 9.14.4 TEVA Business Overview
- 9.14.5 TEVA Recent Developments
- 9.15 Orchid Pharma
- 9.15.1 Orchid Pharma Cephalosporin Basic Information
- 9.15.2 Orchid Pharma Cephalosporin Product Overview
- 9.15.3 Orchid Pharma Cephalosporin Product Market Performance
- 9.15.4 Orchid Pharma Business Overview
- 9.15.5 Orchid Pharma Recent Developments
- 9.16 Taj Pharmaceuticals
- 9.16.1 Taj Pharmaceuticals Cephalosporin Basic Information
- 9.16.2 Taj Pharmaceuticals Cephalosporin Product Overview
- 9.16.3 Taj Pharmaceuticals Cephalosporin Product Market Performance
- 9.16.4 Taj Pharmaceuticals Business Overview
- 9.16.5 Taj Pharmaceuticals Recent Developments
- 9.17 Covalent Laboratories
- 9.17.1 Covalent Laboratories Cephalosporin Basic Information
- 9.17.2 Covalent Laboratories Cephalosporin Product Overview
- 9.17.3 Covalent Laboratories Cephalosporin Product Market Performance
- 9.17.4 Covalent Laboratories Business Overview
- 9.17.5 Covalent Laboratories Recent Developments
- 9.18 United Laboratories
- 9.18.1 United Laboratories Cephalosporin Basic Information
- 9.18.2 United Laboratories Cephalosporin Product Overview
- 9.18.3 United Laboratories Cephalosporin Product Market Performance
- 9.18.4 United Laboratories Business Overview
- 9.18.5 United Laboratories Recent Developments
- 9.19 Aurobindo
- 9.19.1 Aurobindo Cephalosporin Basic Information
- 9.19.2 Aurobindo Cephalosporin Product Overview
- 9.19.3 Aurobindo Cephalosporin Product Market Performance
- 9.19.4 Aurobindo Business Overview
- 9.19.5 Aurobindo Recent Developments
- 9.20 Wockhardt
- 9.20.1 Wockhardt Cephalosporin Basic Information
- 9.20.2 Wockhardt Cephalosporin Product Overview
- 9.20.3 Wockhardt Cephalosporin Product Market Performance
- 9.20.4 Wockhardt Business Overview
- 9.20.5 Wockhardt Recent Developments
- 9.21 LKPC
- 9.21.1 LKPC Cephalosporin Basic Information
- 9.21.2 LKPC Cephalosporin Product Overview
- 9.21.3 LKPC Cephalosporin Product Market Performance
- 9.21.4 LKPC Business Overview
- 9.21.5 LKPC Recent Developments
- 9.22 HPGC
- 9.22.1 HPGC Cephalosporin Basic Information
- 9.22.2 HPGC Cephalosporin Product Overview
- 9.22.3 HPGC Cephalosporin Product Market Performance
- 9.22.4 HPGC Business Overview
- 9.22.5 HPGC Recent Developments
- 9.23 Huafangpharm
- 9.23.1 Huafangpharm Cephalosporin Basic Information
- 9.23.2 Huafangpharm Cephalosporin Product Overview
- 9.23.3 Huafangpharm Cephalosporin Product Market Performance
- 9.23.4 Huafangpharm Business Overview
- 9.23.5 Huafangpharm Recent Developments
- 10 Cephalosporin Market Forecast by Region
- 10.1 Global Cephalosporin Market Size Forecast
- 10.2 Global Cephalosporin Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Cephalosporin Market Size Forecast by Country
- 10.2.3 Asia Pacific Cephalosporin Market Size Forecast by Region
- 10.2.4 South America Cephalosporin Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Cephalosporin by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Cephalosporin Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Cephalosporin by Type (2024-2029)
- 11.1.2 Global Cephalosporin Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Cephalosporin by Type (2024-2029)
- 11.2 Global Cephalosporin Market Forecast by Application (2024-2029)
- 11.2.1 Global Cephalosporin Sales (K MT) Forecast by Application
- 11.2.2 Global Cephalosporin Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook